The study is conducted in Africa, Asia, Europe, Japan, North America and South America. The multinational surveys will explore the experiences and unmet needs of people with diabetes, as well as those of family members of people with diabetes, and of healthcare professionals treating people with diabetes.
Study Type
OBSERVATIONAL
Enrollment
8,985
Three separate survey questionnaires, one for each of the three diabetes groups. Each questionnaire is composed of multiple items including pre-coded (multiple choice) questions, dichotomous (yes/no) questions and rating scales.
Novo Nordisk Investigational Site
Princeton, New Jersey, United States
Novo Nordisk Investigational Site
Algiers, Algeria
Self-reported health and Quality of Life (QoL) (measured by the study questionnaire)
Time frame: Day 1
Psychological well-being of people with diabetes and family members measured by the study questionnaire
Time frame: Day 1
Diabetes distress of people with diabetes and family members measured by the study questionnaire
Time frame: Day 1
Self-reported self-management of people with diabetes measured by the study questionnaire
Time frame: Day 1
Family support behaviours reported by people with diabetes and family members measured by the study questionnaire
Time frame: Day 1
Patient-centred diabetes care reported by people with diabetes and health care professionals measured by the study questionnaire
Time frame: Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Novo Nordisk Investigational Site
Mississauga, Canada
Novo Nordisk Investigational Site
Beijing, Beijing Municipality, China
Novo Nordisk Investigational Site
Copenhagen S, Denmark
Novo Nordisk Investigational Site
Paris La Défense Cedex, France
Novo Nordisk Investigational Site
Mainz, Germany
Novo Nordisk Investigational Site
Bangalore, India
Novo Nordisk Investigational Site
Rome, Italy
Novo Nordisk Investigational Site
Tokyo, Japan
...and 7 more locations